AVAGAST: A randomized, double-blind, placebo-controlled, phase III study of first-line capecitabine and cisplatin plus bevacizumab or placebo in patients with advanced gastric cancer (AGC) Meeting Abstract
| Authors: | Kang, Y.; Ohtsu, A.; Van Cutsem, E.; Rha, S. Y.; Sawaki, A.; Park, S.; Lim, H.; Wu, J.; Langer, B.; Shah, M. A. |
| Abstract Title: | AVAGAST: A randomized, double-blind, placebo-controlled, phase III study of first-line capecitabine and cisplatin plus bevacizumab or placebo in patients with advanced gastric cancer (AGC) |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-06-20 |
| Start Page: | 950s |
| Language: | English |
| ACCESSION: | WOS:000208880800020 |
| DOI: | 10.1200/jco.2010.28.18_suppl.lba4007 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA4007 -- Source: Wos |
